Moreover, tan-CAR T cells were highly efficacious against antigen-specific tumor cells in both in vitro and in vivo experiments with responses that were comparable to the single scFv-CAR T cells directed against BCMA or CD19. The gene discussed is CD19; the disease is neoplasm.